DNMR (Danimer Scientific) Change In Working Capital : $1.29 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific Change In Working Capital?

Danimer Scientific's change in working capital for the quarter that ended in Sep. 2024 was $1.90 Mil.

Danimer Scientific's change in working capital for the fiscal year that ended in Dec. 2023 was $13.50 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Danimer Scientific Change In Working Capital Historical Data

The historical data trend for Danimer Scientific's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific Change In Working Capital Chart

Danimer Scientific Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

8.68

-7.18

-29.40

-19.32

13.50

Danimer Scientific Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Working Capital	Get a 7-Day Free Trial															6.34	-0.99	2.68	-2.31	1.90

Danimer Scientific Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.29 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Danimer Scientific Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Danimer Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (OTCPK:DNMR) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

140 Industrial Boulevard, Bainbridge, GA, USA, 39817

Website

https://www.danimerscientific.com

Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Poland, Belgium, and other regions.

Executives

Richard J Hendrix	director	1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten	officer: Chief Marketing Officer	286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt	director	730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley	director	1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen	director	1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian	director
Michael A Hajost	officer: Chief Financial Officer	C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey	director, officer: CEO & Chairman of the Board	C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt	director	303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D	officer: Chief Technology Officer	1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun	director	2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda	director	1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith	officer: Chief Operating Officer	2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco	director	206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr	10 percent owner, officer: President, other: President	CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367